Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Sell
2,298
-120
-5% -$14K 0.04% 142
2026
Q1
$291K Sell
2,418
-824
-25% -$95.1K 0.04% 124
2025
Q4
$341K Buy
+3,242
New +$304K 0.05% 130
2025
Q1
– Sell
-2,370
Closed -$236K – 169
2024
Q4
$236K Buy
+2,370
New +$244K 0.05% 132

Other funds holding MRK

IFC Advisors's MRK Position: Q2 2026 in Review

IFC Advisors reduced its Merck (MRK) stake by 5% in Q2 2026, selling an estimated $14K and leaving 2,298 shares worth $295K. The position accounts for 0.04% of the portfolio, ranked #142.

IFC Advisors first reported a position in MRK in Q4 2024 and has held it in 4 quarters since. The position peaked at $341K in Q4 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • IFC Advisors held 2,298 shares of Merck worth $295K as of Q2 2026.
  • IFC Advisors sold 120 Merck shares in Q2 2026, an estimated $14K.
  • Merck made up 0.04% of IFC Advisors's portfolio in Q2 2026, its #142 holding.
  • IFC Advisors first reported a position in Merck in Q4 2024 and has held it in 4 quarters since.
  • IFC Advisors's Merck position peaked at $341K in Q4 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on IFC Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.